Search our report database for the most comprehensive and industry trusted market data available today.
We gather information through the use of primary research with the help of our extensive list of medical device, pharmaceutical and dental partners. The experience and data from corporate managers, analysts, doctors and researchers is combined with large databases of hospital procedure numbers, product units sold, average selling prices, internal medical libraries and SEC / FDA filings. This allows us to produce the most comprehensive market research in the industry.
We’ll be happy to discuss your market information needs and suggest the right solution that will help you succeed.
iData empowers its clients to achieve success through making intelligent data-driven decisions.
Our research solutions reflect the needs and strategic challenges of the industries involved. Therefore, we specifically design all of our reports and consulting services to accommodate a wide range of clientele across multiple markets around the world. We provide actionable market intelligence allowing our customers to better navigate the medical market.
AJR study used the LumaGEM® Molecular Breast Imaging System on 1,696 women to detect 13 cancers missed by routine mammograms, reporting MBI yielded a high detection rate and low biopsy rate. Continue reading Clinical Study Confirms LumaGEM®’s Molecular Breast Imaging’s High […]
In anticipation of questions related to the Zika virus, MiMedx is reconfirming the rigorous product safety methods and practices followed by the Company in the processing of its amniotic allografts as well as restating its precise standards for screening of placenta donors. Continue reading MiMedx […]
The €2.29 billion European orthopedic large joint replacement device market includes knee and hip replacement, as well as bone cement utilized with cemented devices. Continue reading Zimmer Biomet, DePuy Synthes Lead European Orthopedic Large Joint Device Market due to Extensive Product […]
The diabetes diagnosis, treatment and drug delivery market is expected to reach a market value of €9.5 billion by 2022. Market growth will be driven by the increasing prevalence of diabetes in Europe and technological advancements made in certain segments, particularly insulin pumps and CGM. […]
Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.
Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.
Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.
Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.